Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 358.6%

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 45,400 shares, an increase of 358.6% from the February 13th total of 9,900 shares. Approximately 10.7% of the company’s stock are sold short. Based on an average daily trading volume, of 858,400 shares, the days-to-cover ratio is presently 0.1 days.

Avalon GloboCare Stock Up 5.2 %

ALBT stock opened at $4.88 on Thursday. The company has a 50 day moving average of $4.66 and a two-hundred day moving average of $3.83. The company has a market cap of $5.34 million, a price-to-earnings ratio of -0.24 and a beta of -0.11. Avalon GloboCare has a 12-month low of $2.11 and a 12-month high of $21.60.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.